Terms: = Sarcomas AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
135 results:
1. Genetically engineered mouse model of pleomorphic liposarcoma: Immunophenotyping and histologic characterization.
Brown JM; Patel R; Smith-Fry K; Ward M; Oliver T; Jones KB
Neoplasia; 2024 Feb; 48():100956. PubMed ID: 38199172
[TBL] [Abstract] [Full Text] [Related]
2. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
3. Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database.
Mochizuki T; Ikegami M; Akiyama T
Cancer Sci; 2024 Feb; 115(2):575-588. PubMed ID: 38115234
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of PRL2 Upregulates pten and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models.
Nguele Meke F; Bai Y; Ruiz-Avila D; Carlock C; Ayub J; Miao J; Hu Y; Li Q; Zhang ZY
Cancer Res Commun; 2024 Jan; 4(1):5-17. PubMed ID: 38047587
[TBL] [Abstract] [Full Text] [Related]
5. The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model.
Lohberger B; Kaltenegger H; Eck N; Glänzer D; Leithner A; Kretschmer N
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958891
[TBL] [Abstract] [Full Text] [Related]
6. Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and pten/PI3K/AKT pathway in osteosarcoma cells.
Yang J; Jiang H; Fu Q; Qin H; Li Y; Liu M
J Photochem Photobiol B; 2023 Dec; 249():112814. PubMed ID: 37956614
[TBL] [Abstract] [Full Text] [Related]
7. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
[TBL] [Abstract] [Full Text] [Related]
8. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
9. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
[TBL] [Abstract] [Full Text] [Related]
10. HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the pten/PI3K/AKT pathway.
Tong Z; Shen Y; Yuan Q; Yu H
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119553. PubMed ID: 37527738
[TBL] [Abstract] [Full Text] [Related]
11. A Phase I/II Investigation of Safety and Efficacy of Nivolumab and
Gordon EM; Angel NL; Omelchenko N; Chua-Alcala VS; Moradkhani A; Quon D; Wong S
Anticancer Res; 2023 May; 43(5):1993-2002. PubMed ID: 37097693
[TBL] [Abstract] [Full Text] [Related]
12. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
Liao X; Lai J; Lin J; Zhang D
Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
[TBL] [Abstract] [Full Text] [Related]
13. A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance.
Doghish AS; Hegazy M; Ismail A; El-Mahdy HA; Elsakka EGE; Elkhawaga SY; Elkady MA; Yehia AM; Abdelmaksoud NM; Mokhtar MM
Pathol Res Pract; 2023 May; 245():154442. PubMed ID: 37031532
[TBL] [Abstract] [Full Text] [Related]
14. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
[No Abstract] [Full Text] [Related]
15. Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.
Vanni I; Pastorino L; Tanda ET; Andreotti V; Dalmasso B; Solari N; Mascherini M; Cabiddu F; Guadagno A; Coco S; Allavena E; Bruno W; Pietra G; Croce M; Gangemi R; Piana M; Zoppoli G; Ferrando L; Spagnolo F; Queirolo P; Ghiorzo P
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901733
[TBL] [Abstract] [Full Text] [Related]
16. PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin.
Si Z; Shen Z; Luan F; Yan J
J Orthop Surg Res; 2023 Feb; 18(1):132. PubMed ID: 36823640
[TBL] [Abstract] [Full Text] [Related]
17. The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.
Hebron KE; Wan X; Roth JS; Liewehr DJ; Sealover NE; Frye WJE; Kim A; Stauffer S; Perkins OL; Sun W; Isanogle KA; Robinson CM; James A; Awasthi P; Shankarappa P; Luo X; Lei H; Butcher D; Smith R; Edmondson EF; Chen JQ; Kedei N; Peer CJ; Shern JF; Figg WD; Chen L; Hall MD; Difilippantonio S; Barr FG; Kortum RL; Robey RW; Vaseva AV; Khan J; Yohe ME
Clin Cancer Res; 2023 Jan; 29(2):472-487. PubMed ID: 36322002
[TBL] [Abstract] [Full Text] [Related]
18. Multivariate evaluation of prognostic markers in synovial sarcoma.
Larque AB; Lozano-Calderon S; Cote GM; Chen YL; Hung YP; Deshpande V; Nielsen GP; Chebib I
J Clin Pathol; 2023 Dec; 77(1):16-21. PubMed ID: 36288948
[TBL] [Abstract] [Full Text] [Related]
19. A phase II study of TAS-117 in patients with advanced solid tumors harboring germline
Rodón J; Funchain P; Laetsch TW; Arkenau HT; Hervieu A; Singer CF; Murciano-Goroff YR; Chawla SP; Anthony K; Yamamiya I; Liu M; Halim AB; Benhadji KA; Takahashi O; Delaloge S
Future Oncol; 2022 Sep; 18(30):3377-3387. PubMed ID: 36039910
[TBL] [Abstract] [Full Text] [Related]
20. Small Cell and Other Rare Histologic Types of Cervical Cancer.
Marchocki Z; Swift B; Covens A
Curr Oncol Rep; 2022 Nov; 24(11):1531-1539. PubMed ID: 35947285
[TBL] [Abstract] [Full Text] [Related]
[Next]
